799-8369165-2/10001/1

Amgen, Inc. — FEI 2026154

Refusal Details

Date
December 11, 2025
Country
United States
Product Category
Drugs and Biologics
Product Code
62QCA99 ANTI-RHEUMATIC N.E.C.
Charges
75